Skip to main content

Table 3 Comparison of adverse events occurrence between Atorvastatin and Rosuvastatin

From: Pharmacogenomic insights into atorvastatin and rosuvastatin adverse effects: a prospective observational study in the UAE’s multiethnic population

Adverse Drug Reaction

Atorvastatin

(N = 352)

Rosuvastatin

(N = 323)

P- value

SAMS

96 (27.27%)

96 (29.7%)

0.4811

Headache

14 (4%)

12 (3.8%)

0.772

Fatigue

14 (4%)

21 (6.5%)

0.135

GI Symptoms

(Constipation, Diarrhea, Indigestion)

16 (4.5%)

33 (10.2%)

0.0035

New incidence of T2DM

30 (8.5%)

41(12.7%)

0.0730

Elevated Liver Enzymes

12(3.4%)

44(13.6%)

< 0.0001

  1. GI; gastrointestinal, T2DM; Type II Diabetes, SAMS; Statin induced muscle symptoms